【摘要】：目的：通過對子宮頸癌患者術(shù)前MRI分期與術(shù)后病理分期結(jié)果的比較,來探討MRI檢查在診斷子宮頸癌臨床分期中的應(yīng)用價(jià)值。 方法：從大連醫(yī)科大學(xué)附屬第一醫(yī)院2012年1月至2013年10月間收入的子宮頸癌患者中隨機(jī)抽取60例,對臨床資料完整的58例患者進(jìn)行分析。所有患者均已經(jīng)組織病理學(xué)檢查確診為子宮頸癌并首次治療均選擇手術(shù)治療,對行手術(shù)治療的58例患者進(jìn)行統(tǒng)計(jì)學(xué)分析,并對其術(shù)前MRI分期結(jié)果與術(shù)后手術(shù)病理分期結(jié)果進(jìn)行對比分析。 結(jié)果：根據(jù)MRI結(jié)果判斷,58例患者中,ⅠA期0例,ⅠB期14例,ⅡA期27例,ⅡB期9例。經(jīng)手術(shù)組織病理學(xué)檢測I A期7例,ⅠB期15例,ⅡA期26例,ⅡB期10例。診斷符合率77.59%,ⅠA期子宮頸癌MRI無法診斷,ⅠB期MRI診斷準(zhǔn)確率為93.33%,ⅡA期MRI診斷準(zhǔn)確率為92.31%,ⅡB期MRI診斷準(zhǔn)確率為70%； 本次研究顯示MRI對于子宮頸癌子宮轉(zhuǎn)移敏感度為89.47%,特異度為85.00%,準(zhǔn)確率為87.93%,陽性預(yù)測值為91.89%； 本次研究顯示MRI對于子宮頸癌宮旁轉(zhuǎn)移敏感度為70%,特異度為95.83%,準(zhǔn)確率為91.38%,陽性預(yù)測值為77.78%； 本次研究顯示MRI對于子宮頸癌陰道轉(zhuǎn)移敏感度為86.11%,特異度為90.91%,準(zhǔn)確率為87.93%,陽性預(yù)測值為93.94%； 結(jié)論：1、ⅠA期子宮頸癌患者M(jìn)RI成像無明顯異常,無法通過MRI做出正確診斷。 2、MRI對ⅠB-ⅡB期子宮頸癌分期有較高的準(zhǔn)確性,可作為子宮頸癌患者術(shù)前必須輔助檢查之一。 3、MRI對判斷子宮頸癌子宮、陰道、宮旁轉(zhuǎn)移情況均有較高的敏感性和準(zhǔn)確性。
[Abstract]:Objective: to evaluate the value of MRI in the diagnosis of cervical carcinoma by comparing the results of preoperative MRI staging with postoperative pathological staging. Methods: sixty patients with cervical cancer were randomly selected from the first affiliated Hospital of Dalian Medical University from January 2012 to October 2013. 58 patients with complete clinical data were analyzed. All the patients were diagnosed as cervical cancer by histopathological examination and were treated with surgical treatment for the first time. The results of preoperative MRI staging and postoperative pathological staging were compared and analyzed. Results: according to the results of MRI, there were 0 cases of stage 鈪，

本文編號(hào)：2365664